Stigma-Treatment Enhanced Incentivized Directly Observed Therapy for People with HIV who Inject Drugs
针对注射吸毒艾滋病毒感染者的耻辱治疗强化激励直接观察治疗
基本信息
- 批准号:10472519
- 负责人:
- 金额:$ 29.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdoptionAnti-Retroviral AgentsCaringCognitive TherapyCommunitiesContinuity of Patient CareCoupledDataDevelopmentDirectly Observed TherapyDoseEffectivenessEffectiveness of InterventionsEnsureFrequenciesHIVHealthIncentivesInfrastructureInjecting drug userInterventionInterviewLeadMassachusettsMethodsMonitorParticipantPersonsPharmaceutical PreparationsProviderPublic HealthRandomized Controlled TrialsResourcesSubstance Use DisorderTestingTherapeutic InterventionTimeViralVisitWorkacceptability and feasibilityavoidance behaviorbasebehavioral adherencecontingency managementdesigneffectiveness testingevidence baseexperiencefeasibility testingfollow-uphybrid type 1 designimplementation scienceimplementation strategyimprovedincentive-based interventioninformantinterestinternalized stigmamobile applicationmultiphase optimization strategypublic health prioritiessocial stigmasubstance usetherapy designtransmission processvideo deliveryvirtual delivery
项目摘要
PROJECT ABSTRACT
People who inject drugs (PWID) are less likely to maintain viral suppression, perpetuating HIV transmission
among PWID over the past two years in Massachusetts. While resource intensive intervention strategies (i.e.,
incentive-based interventions and directly observed therapy (DOT)) have demonstrated effectiveness for
improving ART adherence in the short-term, they do not address underlying barriers to engagement in HIV
care for PWID, such internalized and anticipated stigma. Acceptable, feasible, and scalable intervention
strategies that combine these intervention strategies with an evidence-based cognitive behavioral therapy
(CBT) intervention designed to address internalized and anticipated stigma related to substance use, as well
as other related stigmas (e.g., HIV) and their sequelae (e.g., avoidance behaviors) optimized for PWID may
result in sustained adherence and viral suppression over time. We hypothesize that combining an app-based
video-delivered optimized stigma-focused CBT intervention coupled with app-based video-delivered short-term
incentivized DOT will have longer lasting effects than short-term incentivized DOT alone. To test this
hypothesis, data on the feasibility, acceptability, and scalability of a combined intervention, optimized for PWID,
is needed. In this R34 we will leverage the multiphase optimization strategy (MOST) to facilitate the
optimization of an evidence-based video-delivered stigma-focused CBT intervention for PWID living with HIV in
Massachusetts who are not virally suppressed (aim 1). We will then utilize implementation science strategies in
a Hybrid Type 1 design to simultaneously conduct a pilot randomized controlled trial (RCT) to test the feasibility
and acceptability of the optimized stigma-focused CBT intervention paired with incentivized DOT compared to
incentivized DOT alone, both implemented through a tailored mobile app (emocha®; n=70; aim 2), while
rigorously testing the implementation strategy, including scalability (aim 3). By accomplishing these aims, we
will develop and refine critical components of the intervention, including optimizing the stigma-focused CBT
intervention and assessing the acceptability, feasibility, and preliminary scalability of combined intervention.
This R34 will enable the development and refinement of the infrastructure for a fully powered RCT, which will
be submitted as a subsequent R01 to test the effectiveness of the intervention and scalability. Throughout this
R34 and the subsequent R01, we will work closely with the Massachusetts Department of Public Health, given
their interest in implementing this intervention strategy and platform should it be identified as effective and
scalable.
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Abigail Winston Batchelder其他文献
Abigail Winston Batchelder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Abigail Winston Batchelder', 18)}}的其他基金
Mitigating the Impact of Stigma and Shame as a Barrier to Viral Suppression Among MSM Living with HIV and Substance Use Disorders
减轻耻辱感和羞耻感对感染艾滋病毒和药物滥用的 MSM 的病毒抑制造成的影响
- 批准号:
10683694 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Stigma-Treatment Enhanced Incentivized Directly Observed Therapy for People with HIV who Inject Drugs
针对注射吸毒艾滋病毒感染者的耻辱治疗强化激励直接观察治疗
- 批准号:
10668323 - 财政年份:2021
- 资助金额:
$ 29.59万 - 项目类别:
Stigma-Treatment Enhanced Incentivized Directly Observed Therapy for People with HIV who Inject Drugs
针对注射吸毒艾滋病毒感染者的耻辱治疗强化激励直接观察治疗
- 批准号:
10227320 - 财政年份:2021
- 资助金额:
$ 29.59万 - 项目类别:
Understanding and Addressing Internalized Stigma and Shame as Barriers to Engagement in HIV Care among Men who Have Sex with Men who Use Substances.
了解并解决与使用药物的男性发生性关系的男性参与艾滋病毒护理的障碍的内在耻辱和羞耻感。
- 批准号:
10166815 - 财政年份:2017
- 资助金额:
$ 29.59万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Fellowship Programs